Literature DB >> 15276713

CAR: detailing new models.

Bryan Goodwin1, John T Moore.   

Abstract

Functional analysis has broadened our understanding of the physiological roles of the two related nuclear receptors pregnane X receptor (PXR; NR1I2) and constitutive androstane receptor (CAR; NR1I3). Initial research focused on the role of these two receptors in xenobiotic detoxification and, more recently, additional functional roles for CAR have been identified. Specifically, CAR activity has been shown to ameliorate the effects of hyperbilirubinemia, caloric restriction and toxic bile acids. Thus, the physiological role of CAR has broadened to include responses to metabolic and nutritional stress. These data highlight potential new opportunities in targeting CAR for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276713     DOI: 10.1016/j.tips.2004.06.007

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  10 in total

1.  Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes.

Authors:  Jian Yang; Chunshu Hao; Dongfang Yang; Deshi Shi; Xiulong Song; Xiaofei Luan; Gang Hu; Bingfang Yan
Journal:  Toxicol Lett       Date:  2010-06-09       Impact factor: 4.372

2.  Ortho-aminoazotoluene activates mouse constitutive androstane receptor (mCAR) and increases expression of mCAR target genes.

Authors:  Mariya A Smetanina; Mariya Y Pakharukova; Svitlana M Kurinna; Bingning Dong; Juan P Hernandez; David D Moore; Tatyana I Merkulova
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-06       Impact factor: 4.219

3.  Circadian clock regulates response to pesticides in Drosophila via conserved Pdp1 pathway.

Authors:  Laura Michelle Beaver; Louisa Ada Hooven; Shawn Michael Butcher; Natraj Krishnan; Katherine Alice Sherman; Eileen Shin-Yeu Chow; Jadwiga Maria Giebultowicz
Journal:  Toxicol Sci       Date:  2010-03-26       Impact factor: 4.849

Review 4.  Pharmacokinetic considerations in the treatment of CNS tumours.

Authors:  Susannah Motl; Yanli Zhuang; Christopher M Waters; Clinton F Stewart
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 5.  Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents.

Authors:  Aldo-D Mottino; Viviana-A Catania
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

Review 6.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

7.  Compartment-specific gene regulation of the CAR inducer efavirenz in vivo.

Authors:  H E Meyer zu Schwabedissen; S Oswald; C Bresser; A Nassif; C Modess; Z Desta; E T Ogburn; M Marinova; D Lütjohann; C Spielhagen; M Nauck; H K Kroemer; W Siegmund
Journal:  Clin Pharmacol Ther       Date:  2012-05-16       Impact factor: 6.875

Review 8.  Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer.

Authors:  Enrico Garattini; Marco Bolis; Maurizio Gianni'; Gabriela Paroni; Maddalena Fratelli; Mineko Terao
Journal:  Oncotarget       Date:  2016-07-05

9.  Inhibition of cytochrome P450 3A in rat liver by the Diorganotin (IV) compound di-n-Butyl-di-(4-chlorobenzo-hydroxamato)tin (IV) and Its Probable Mechanism.

Authors:  Yunxia Zhang; Yunlan Li; Qingshan Li
Journal:  Molecules       Date:  2012-09-12       Impact factor: 4.411

10.  Cecropin B Represses CYP3A29 Expression through Activation of the TLR2/4-NF-κB/PXR Signaling Pathway.

Authors:  Xiaoqiao Zhou; Xiaowen Li; Xiliang Wang; Xiue Jin; Deshi Shi; Jun Wang; Dingren Bi
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.